Dr. Nathan Lack

Dr. Nathan Lack, Vancouver Prostate Centre, University of British Columbia, Canada, US School of Medicine, Koç University, Turkey

Nathan Lack (PhD) is a Senior Research Scientist at the Vancouver Prostate Centre. His laboratory works to better understand the molecular underpinnings of prostate cancer to develop more effectively treatments for this common disease. This work has been published in Nature, Cell, Genome Biology and others. In addition to his academic research, Nathan was involved in the development of the FDA-approved therapeutic Plerixafor and also identified BF3-targeting anti-androgens that are currently in clinical development to treat Kennedy’s disease. The Lack laboratory is supported by extensive funding from national, international and industrial sources.